Stock vs Stock Comparison

Arcturus Therapeutics Holdings Inc. vs Agilent Technologies, Inc.

A wins the Tale of the Tape 8–1.

ARCT$6.05
A$131.46

🏆 Tale of the Tape

18
ARCTA
-97.9%Profitability (Net Margin)18.8%
Valuation (P/E)27.3x
-22.1%Efficiency (ROIC)11.8%
1/9Health (Piotroski F)5/9
0.2Safety (Altman Z)5.0
-51.4%Growth (Rev YoY)6.7%
0.31Risk (Sharpe 1Y)0.47
0.27xBalance Sheet (D/E)0.89x
-1110.66%FCF Yield3.00%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.254
252-Day Correlation
0.236
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricARCTA
Market Cap$0.2B$37.1B
P/E Ratio27.3x
Forward P/E-1.5x19.9x
P/B0.90x5.21x
Dividend Yield0.75%
Beta2.361.25

Quantitative Metrics

MetricARCTA
DCF Fair Value$51.48
DCF Upside-60.8%
Piotroski F1/95/9
Altman Z0.195.03
Beneish M-2.46
FCF Yield-1110.66%3.00%
Net Debt/EBITDA0.7x
ROIC-22.1%11.8%
WACC11.9%
ROIC – WACC-0.1pp
Gross Margin52.4%
Net Margin-97.9%18.8%
Rev Growth YoY-51.4%6.7%
Sharpe (1Y)0.310.47
Max Drawdown 3Y-86.7%
FCF Payout Ratio24%

ARCT Price

Loading chart...

A Price

Loading chart...

ETF Exposure

ARCT found in:

VHT0.00%

A found in:

MOAT1.31%
VOT0.82%
XLV0.66%
VHT0.55%
VO0.36%
ONEV0.25%
RSP0.19%
VIG0.16%
VTV0.14%
SPYV0.13%
SCHV0.12%
VONV0.11%
IWD0.11%
ONEO0.10%
QUS0.09%
ESGV0.07%
SPLG0.07%
IVV0.06%
VOO0.06%
SPY0.06%
SPTM0.06%
ITOT0.06%
SCHX0.06%
SCHB0.05%
VTI0.05%
VONE0.05%
URTH0.04%
ACWI0.03%
DGRW0.03%
VT0.03%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

ARCT vs A: Head-to-Head Analysis

Arcturus Therapeutics Holdings Inc. (ARCT) and Agilent Technologies, Inc. (A) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, A leads 8–1 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, ARCT generates a return on invested capital (ROIC) of -22.1% compared to A's 11.8%. This suggests A is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between ARCT and A is 0.254, indicating low correlation, making them an effective diversification pair in a portfolio context.

ARCT appears in 1 ETF tracked by SecuritiesDB, while A appears in 30 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, ARCT or A?

Our quantitative analysis compares ARCT and A across nine fundamental dimensions. A wins the Tale of the Tape 8–1. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are ARCT and A correlated?

The 252-day correlation between ARCT and A is 0.254. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.